Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is providing ...
There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...
To clone (download) this repository, you can use the Code button at the top left of the screen, or use the following command if you have git installed git clone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback